Initiating antiretroviral therapy

R. L. Murphy*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


There are currently multiple approaches that are effective in patients initiating antiretroviral therapy Recommended treatment choices are based on a dual combination 'backbone' consisting of two nucleoside reverse transcriptase inhibitors plus a protease inhibitor or non-nucleoside reverse transcriptase inhibitor. A novel approach being studied is a regimen that consists of three nuclesides only. Therapeutic decisions need to encompass a long-term strategy that is individualized and likely to provide optimal viral suppression that is tolerable as well as effective.

Original languageEnglish (US)
Pages (from-to)172-176
Number of pages5
JournalInternational Antiviral News
Issue number12
StatePublished - Dec 1 1999

ASJC Scopus subject areas

  • Pharmacology
  • Virology


Dive into the research topics of 'Initiating antiretroviral therapy'. Together they form a unique fingerprint.

Cite this